XML 103 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
TRANSACTION AND REORGANIZATION EXPENSES
12 Months Ended
Dec. 31, 2019
Restructuring and Related Activities [Abstract]  
TRANSACTION AND REORGANIZATION EXPENSES
For the year ended December 31, 2019, reorganization expenses were $37 million (2018: $67 million), respectively, related to the Company's transformation program which was launched in 2017. This program encompasses the integration of Novae which commenced in the fourth quarter of 2017, the realignment of the Company's accident and health business, together with other initiatives designed to increase efficiency and enhance profitability while delivering a customer-centric operating model.

For the year ended December 31, 2017, transaction and reorganization expenses were $27 million which included transaction costs incurred in connection with the acquisition of Novae, such as due diligence, legal, accounting, investment banking fees and expenses, as well as integration expenses related to the integration of Novae into the Company's operations and compensation-related costs associated with the termination of certain employees.